(Reuters) — AmSurg (NSDQ:AMSG) yesterday withdrew its offer to buy TeamHealth Holdings (NYSE:TMH), after its revised bid was rejected by the medical staffing company. AmSurg said it decided to drop the bid as the TeamHealth board had refused to engage in discussions. TeamHealth said earlier yesterday that the revised proposal undervalued the company. AmSurg had raised the cash component of its […]
(Reuters) — Medical staffing company TeamHealth Holdings today rejected AmSurg‘s revised buyout offer that, despite an increase in the cash component, was lower than AmSurg’s previous offer. A deal would make the combination a leading provider of medical staff such as radiologists, anesthesiologists and physicians for ambulatory surgery and primary care. Earlier today, AmSurg had raised the cash […]
(Reuters) — AmSurg proposed a $5.3 billion merger with TeamHealth Holdings Inc as it looks to add heft to its business that provides doctors to hospitals and other healthcare services. AmSurg, which revealed on today that private merger talks with TeamHealth fell through in September, said it had gone public with the offer to persuade TeamHealth […]
(Reuters) — Evolent Health‘s initial public offering priced at $17 per share, an underwriter told Reuters late yesterday, valuing the healthcare software maker at about $950 million. The company’s IPO raised about $195.5 million at that price, which was above its expected range of $14-$16 and nearly double its initial estimate. The Arlington, Va.-based company, which is […]
By Robert Schultz
Hospital executives are increasingly involved in decision-making when it comes to their organizations’ medical device spends and are looking for ways to collaborate with medtech to drive value, according to a panel of hospital CEOs at the MassMEDIC annual conference this week in Boston.
When it comes to policy issues, it was good news/bad news for attendees of the 2015 MedTech Investing Conference in Minneapolis.
Evolent Health today registered for a $100 million initial public offering for its value-based healthcare software platform as it looks to capitalize on its estimated $10 billion market.
Arlington, Va.-based Evolent, founded in 2011, said it plans to list on the New York Stock Exchange under the "EVH" symbol.